NASDAQ:JJSF
J & J Snack Foods Corp. Stock News
$164.15
-1.43 (-0.86%)
At Close: May 17, 2024
Better Coronavirus Stock: Johnson & Johnson vs. Novavax | The Motley Fool
10:14am, Saturday, 10'th Oct 2020
These COVID-19 vaccine leaders offer very different risk-reward propositions.
U.S. corporate earnings reports will shine a light on the uneven playing field in the year of the pandemic
06:56pm, Friday, 09'th Oct 2020
The U.S. third-quarter corporate earnings reporting season will kick off next week and the numbers will reflect a second quarter dominated by the coronavirus...
5 ETFs That Make Attractive Investment Choices in Q4
12:00am, Thursday, 08'th Oct 2020
Stocks Analysis by Zacks Investment Research covering: Adobe Systems Incorporated, Activision Blizzard Inc, Johnson & Johnson, Salesforce.com Inc. Read Zacks Investment Research's latest article on In
Trump ‘looking forward’ to next presidential debate
03:38pm, Tuesday, 06'th Oct 2020
WASHINGTON: President Donald Trump said Tuesday he wants the next debate against his Democratic challenger Joe Biden to go ahead despite his bout of coronavirus. “I am looking forward to the debate
Cardiovascular Drugs Market According to latest research on focusing on Leading Manufacturers
09:53am, Tuesday, 06'th Oct 2020
Oct 06, 2020 (AmericaNewsHour) --
Global Cardiovascular Drugs Market - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024Overview:...
Johnson & Johnson settles baby powder lawsuits for $100M
05:40pm, Monday, 05'th Oct 2020
Johnson & Johnson will pay more than $100 million to settle over 1,000 lawsuits that allege the company’s Baby Powder caused cancer, Bloomberg News reported on Monday, citing people with …
Johnson & Johnson to pay about US$100-million to settle more than 1,000 talc lawsuits: report
04:33pm, Monday, 05'th Oct 2020
J&J faces more than 19,000 lawsuits from consumers and their survivors claiming its talc products caused cancer owing to contamination with asbestos
Johnson & Johnson to pay more than $100 million to settle over 1,000 talc lawsuits: Bloomberg
12:00am, Monday, 05'th Oct 2020
Johnson & Johnson to pay more than $100 million to settle over 1,000 talc lawsuits: Bloomberg
Where the Covid-19 Vaccines Stand Ahead of the Expert Panels
11:30am, Friday, 02'nd Oct 2020
Canaccord Genuity analysts examined candidates for coronavirus vaccines among AstraZeneca, Pfizer/BioNTech, Moderna, Johnson & Johnson, and Novavax.
California State Teachers Retirement System Sells 408 Shares of J & J Snack Foods Corp (NASDAQ:JJSF)
07:16am, Sunday, 27'th Sep 2020
California State Teachers Retirement System cut its stake in shares of J & J Snack Foods Corp (NASDAQ:JJSF) by 1.8% during the 2nd quarter, according to the company in its most recent disclosure with
There are four coronavirus vaccines in late-stage studies; here’s how they differ
06:44pm, Friday, 25'th Sep 2020
Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so...
J&J: most Phase 1/2a participants in COVID-19 vaccine developed neutralizing antibodies
04:23pm, Friday, 25'th Sep 2020
Shares of Johnson & Johnson undefined were up 0.1% in trading on Friday after data from the Phase 1/2a clinical trial for its COVID-19 vaccine candidate was...
Positive results for J&J vaccine; child racial disparities seen
12:00am, Friday, 25'th Sep 2020
Positive results for J&J vaccine; child racial disparities seen
Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine
10:16pm, Thursday, 24'th Sep 2020
The company said it will start a Phase 3 trial of its vaccine among 10,000 volunteers in the U.K.
COVID-19 vaccine: Johnson & Johnson begins huge trial testing one-dose shot - Businessday NG
08:57am, Thursday, 24'th Sep 2020
A huge international study of a COVID-19 vaccine that aims to work with just one dose is underway as Johnson & Johnson begins dosing up to 60,000 volunteers,
